Sun Pharmaceutical Industries
SUNPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Israel Makov · MD: Dilip S Shanghvi · Listing date: Feb. 8, 1995 · Employees: 37000 · Mumbai · http://www.sunpharma.com

Stock Price vs Company Growth
1d
0.6%
1w
3.7%
1m
7.1%
3m
5.1%
6m
1.3%
1y
25.9%
5y
33.6%
10y
7.5%
all
18.1%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowJun08Sep11Dec14Mar18Jun21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

1,755 0.6%
1,694
1,910
Company Overview

Sales
50,308 Cr
Growth: 8.7%
Profit after Tax
11,054 Cr
Growth: 6.4%
Large Cap
4,21,083 Cr
P/E: 38.1x
Industry P/E: 33.4x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 50,308
Growth 8.7%
EBITDA 27.4%
P/S 8.4x
Dividend 0.9%
P/E 38.1x
Book Value ₹ 290
PEG Ratio 4.3x
ROE 16.8%
P/B 6.0x
Shareholding Pattern

Institutions
Life Insurance Corporation Of India
7.37 %
Icici Prudential Value Discovery Fund And Various Fund Accounts
3.68 %
Sbi-Etf Nifty 50 And Various Fund Accounts
1.94 %
Hdfc Trustee Company Limited-Hdfc Balanced Advantage Fund And Various Fund Accounts
1.37 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund And Various Fund Accounts
1.24 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep22Dec22
Promoters
Shanghvi Finance Private Limited
40.3 %
Dilip.S.Shanghvi
9.6 %
Aditya Medisales Limited
1.67 %
Raksha S.Valia
1.2 %
Sudhir V.Valia
0.6 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep22Dec22
Others
Llp
2.89 %
Lakshdeep Investments & Finance (P) Ltd.
1.18 %
Iepf
0.08 %
Created with Highcharts 8.2.2Sep19Dec19Mar20Jun20Sep20Dec20Mar21Sep22Dec22
Increase    Decrease    No change
Company Profile Detailed

The company is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company. A vertically integrated business and a skilled team enables it to deliver high-quality products, trusted by customers and patients in many countries across the world, at affordable prices.ProductsFormulationsActive Pharmaceutical Ingredients - CramsOTCAwards 2005: Dilip Shanghvi is named Entrepreneur of the Year (Healthcare and Life Science) Ernst & Young.
Investors (335)
Followers (135)